Target intelligence / Profile preview

Microbial cell wall biosynthetic machinery

Molecular classification
Enzyme, Transporter, Other
01

Overview

The microbial cell wall biosynthetic machinery is a complex, multi-step system of enzymes and transporters responsible for creating and maintaining the structural integrity of the bacterial and fungal cell wall (Nature Reviews Microbiology, 2015). In bacteria, this machinery primarily synthesizes peptidoglycan, a mesh-like polymer that protects the cell from osmotic lysis and provides structural support (Journal of Biological Chemistry, 2019). The process involves cytoplasmic synthesis of precursors, their translocation across the inner membrane, and final assembly in the extracytoplasmic space by enzymes such as penicillin-binding proteins (PBPs) (Frontiers in Microbiology, 2021). Because the components of this machinery are essential for microbial survival and lack direct homologs in human cells, they represent some of the most successful targets for antimicrobial therapy (StatPearls, 2023). Drugs targeting this machinery include beta-lactams, which inhibit cross-linking, and glycopeptides, which bind to the peptide precursors to prevent polymerization (StatPearls, 2023). In fungi, the machinery involves the synthesis of chitin and beta-glucans, which are targeted by drugs like echinocandins (Nature Reviews Microbiology, 2017). Therapeutic challenges include the rapid evolution of resistance mechanisms, such as the production of beta-lactamases or the modification of target binding sites (Nature Reviews Microbiology, 2015).

Other names
Bacterial cell wall synthesis pathwayPeptidoglycan biosynthesis machineryFungal cell wall biosynthetic pathwayCell wall assembly machinery
02

Mechanism of action

Inhibition of peptidoglycan cross-linking (transpeptidation), inhibition of precursor synthesis (e.g., MurA), inhibition of lipid carrier recycling, or inhibition of fungal 1,3-beta-glucan synthesis.

03

Biological functions

Cell wall organizationPeptidoglycan biosynthetic processOsmotic protectionCell division
04

Disease associations

Infection
05

Safety considerations

Antimicrobial resistance (AMR)Hypersensitivity and anaphylaxisMicrobiome dysbiosisNephrotoxicity
06

Interacting drugs

Penicillin G

8 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)Presence of resistance genes (e.g., mecA, vanA)Peptidoglycan fragments

Beyond the preview

Go deeper on Microbial cell wall biosynthetic machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial cell wall biosynthetic machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call